Groowe Groowe / Newsroom / HBIO
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

HBIO News

Harvard Bioscience Inc

Form 8-K

sec.gov
HBIO

Form 8-K

sec.gov
HBIO

Harvard Bioscience Announces Reverse Stock Split

globenewswire.com
HBIO

Harvard Bioscience to Participate in KeyBanc’s Virtual Healthcare Forum

globenewswire.com
HBIO

Harvard Bioscience Schedules Fourth Quarter 2025 Earnings Conference Call for March 12, 2026 at 8:00 AM ET

globenewswire.com
HBIO

Harvard Bioscience Announces Preliminary Fourth Quarter Financial Results, Positive Outlook for 2026 & Outlines Long-Term Strategic Focus Areas

globenewswire.com
HBIO

Harvard Bioscience Announces Strategic Consolidation of Manufacturing Operations to Improve Efficiency and Support Long-Term Growth

globenewswire.com
HBIO

Hummingbird Bioscience Announces First Patient Dosed in Phase I Clinical Trial of HMBD-501 in Advanced HER3-Expressing Solid Malignancies

globenewswire.com
HBIO

Harbour BioMed Enters into Long-Term Strategic Collaboration with Lannacheng to Advance Next-Generation Radionuclide Drug Conjugates

prnewswire.com
HBIO

Harvard Bioscience Announces the Successful Completion of Debt Refinancing with Comprehensive Growth Financing Package

globenewswire.com
HBIO